According to the “Guangdong Union Qingkailing and Other Proprietary Chinese Medicines Centralized Volume Procurement Document (GDYJYPDL202103)” regarding “the selected/candidate product has been suspended from production, sales, use, import, etc. by the drug supervision and administration department, and the selection/alternative status is cancelled,” Eddy Injection, a product of Guizhou Yibai Pharmaceutical Co., Ltd. has now been removed from the selection status of Guizhou Yibai Pharmaceutical Co., Ltd.'s centralized procurement of proprietary Chinese medicines such as Qingkailing.
广东省药品交易中心取消贵州益佰制药股份有限公司产品艾迪注射液中选公告
Guangdong Drug Exchange Center cancels Guizhou Yibai Pharmaceutical Co., Ltd. product Eddy's injection selection announcement
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.